生殖遗传学市场－全球产业规模、份额、趋势、机会和预测（按组件、按技术、按程序类型、按应用、按地区和竞争细分，2020-2030 年预测）

2024年全球生殖遗传学市场规模为58.7亿美元，预计到2030年将达到125.6亿美元，预测期内复合年增长率为13.52%。全球生殖遗传学市场正经历显着成长，这得益于发展中国家对基因工程日益增长的认识。此外，医疗检测报销范围的不断扩大以及政府机构对开发新诊断中心的多项投资，显着增加了全球各地对生殖遗传学的需求。此外，先进检测的显着增长，以及不同年龄层女性对安全生活意识的不断提高，预计将进一步增加对生殖遗传学的需求，从而推动市场成长。

关键市场驱动因素

遗传性疾病和不孕症发病率不断上升

主要市场挑战

基因检测的伦理和法律问题

主要市场趋势

非侵入性产前检测（NIPT）需求不断成长

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球生殖遗传学市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按组件（实验室开发的测试、试剂盒和测定、试剂和耗材）
  • 依技术（次世代定序、聚合酶炼式反应、原位杂交、微阵列）
  • 依程序类型（带因者筛检、产前筛检、植入前基因检测、不孕症基因检测）
  • 按应用（非整倍体、单基因疾病、染色体结构异常、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按组件
  • 依技术
  • 依手术类型
  • 按应用
  • 按地区

第六章：北美生殖遗传学市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲生殖遗传学市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太生殖遗传学市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲生殖遗传学市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲生殖遗传学市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 併购
• 产品发布

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品/服务的威胁

第 14 章：全球生殖遗传学市场：SWOT 分析

第 15 章：竞争格局

• CooperSurgical, Inc.
• Centogene AG
• Invitae Corporation
• Illumina, Inc.
• Myriad Genetics, Inc.
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• Quest Diagnostics
• Natera, Inc
• Eurofins Scientific SE

第 16 章：策略建议

第17章调查会社について・免责事项

Global Reproductive Genetics Market was valued at USD 5.87 billion in 2024 and is expected to reach USD 12.56 billion by 2030 with a CAGR of 13.52% during the forecast period. The global market for Reproductive Genetics is experiencing significant growth, driven by the growing awareness towards genetic engineering in the developing countries, to get better. Additionally, growing reimbursement improvements for medical tests and initiative, running parallel to multiple investments by government organizations for developing new diagnostic centers, have significantly increased the demand for reproductive genetics across different parts of the globe. Additionally, significant growth in advanced testing along with increasing awareness among different age group women for leading safe life, are further expected to increase the demand for reproductive genetics, thereby fuelling the market growth.

Key Market Drivers

Increasing Incidence of Genetic Disorders and Infertility

One of the primary growth drivers for the reproductive genetics market is the rising incidence of genetic disorders and infertility worldwide. According to the World Health Organization (WHO), approximately 10% to 15% of couples globally experience infertility, and the number is rising due to changing lifestyles, environmental factors, and delayed family planning. At the same time, the prevalence of heritable genetic conditions such as Down syndrome, cystic fibrosis, and thalassemia has heightened the demand for early detection and diagnosis through genetic testing.

Reproductive genetic testing methods, such as preimplantation genetic testing (PGT), carrier screening, and non-invasive prenatal testing (NIPT), help assess genetic risks in embryos and fetuses, allowing couples to make informed reproductive decisions. For instance, the Centers for Disease Control and Prevention (CDC) has reported that the number of assisted reproductive technology (ART) cycles performed in the United States has grown steadily, reaching nearly 330,000 cycles in 2021. Many of these ART cycles now integrate reproductive genetic tests to ensure healthy pregnancies.

Governments across Europe and Asia are also promoting national screening programs for conditions such as thalassemia and Tay-Sachs disease, particularly in high-prevalence regions. Such public health initiatives have further solidified the role of genetic diagnostics in reproductive health. Consequently, as the burden of infertility and inherited disorders continues to rise, reproductive genetic testing is becoming a critical part of reproductive healthcare globally.

Key Market Challenges

Ethical and Legal Concerns Surrounding Genetic Testing

One of the most pressing challenges facing the reproductive genetics market is the complex web of ethical and legal issues. Genetic testing, especially in the context of reproduction, raises serious concerns related to privacy, consent, genetic discrimination, and the potential for "designer babies." The ethical dilemma is particularly pronounced in prenatal and preimplantation genetic testing, where the ability to select embryos based on genetic characteristics has sparked debates about eugenics and social equity. Laws vary widely across countries. For example, Germany strictly regulates embryo selection, while the United States offers broader flexibility, often guided by private clinics' policies.

There is also concern about data protection. Genetic information is highly sensitive, and breaches can lead to discrimination in insurance and employment. While regulations like the Genetic Information Nondiscrimination Act (GINA) in the U.S. provide some protection, gaps still exist in areas such as long-term care insurance. Moreover, reproductive genetic testing may disproportionately benefit higher-income groups, exacerbating healthcare disparities. In countries without universal healthcare, the high cost of these tests may place them out of reach for many, even though government-supported initiatives are increasing access.

Key Market Trends

Rising Demand for Non-Invasive Prenatal Testing (NIPT)

A major trend reshaping the global reproductive genetics landscape is the increasing adoption of non-invasive prenatal testing (NIPT). This technique analyzes cell-free fetal DNA circulating in maternal blood to detect chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18, and trisomy 13 as early as the 10th week of pregnancy. NIPT has gained rapid clinical acceptance due to its safety (as it avoids amniocentesis or chorionic villus sampling), high sensitivity, and low false-positive rates. According to the American College of Obstetricians and Gynecologists (ACOG), NIPT is now recommended for all pregnant women regardless of age or risk level. This policy shift has dramatically expanded the target patient population.

Globally, many countries have integrated NIPT into public health strategies. For instance, in 2021, the Netherlands became one of the first countries to fully reimburse NIPT as part of routine prenatal screening. Similar policies are being adopted in Canada, Germany, and parts of Asia, including China and Japan. Furthermore, technological innovations such as single-molecule sequencing and machine learning-based analysis platforms are making NIPT more accurate and cost-effective. With a growing number of pregnancies being managed with NIPT, this trend is expected to substantially boost demand for reproductive genetic services over the next decade.

Key Market Players

• CooperSurgical, Inc.
• Centogene AG
• Invitae Corporation
• Illumina, Inc.
• Myriad Genetics, Inc.
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• Quest Diagnostics
• Natera, Inc
• Eurofins Scientific SE

Report Scope:

In this report, the Global Reproductive Genetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Reproductive Genetics Market, By Component:

• Laboratory Developed Tests
• Kits & Assays
• Reagents & Consumables

Reproductive Genetics Market, By Technology:

• Next Generation Sequencing
• Polymerase Chain Reaction
• In Situ Hybridization
• Microarrays

Reproductive Genetics Market, By Procedure Type:

• Carrier Screening
• Prenatal Screening
• Preimplantation Genetic Testing
• Infertility Genetic Testing

Reproductive Genetics Market, By Application:

• Aneuploidy
• Single Gene Disorder
• Structural Chromosomal Abnormality
• Others

Reproductive Genetics Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Reproductive Genetics Market.

Available Customizations:

Global Reproductive Genetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Reproductive Genetics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Laboratory Developed Tests, Kits & Assays, Reagents & Consumables)
  • 5.2.2. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays)
  • 5.2.3. By Procedure Type (Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, Infertility Genetic Testing)
  • 5.2.4. By Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Component
  • 5.3.2. By Technology
  • 5.3.3. By Procedure Type
  • 5.3.4. By Application
  • 5.3.5. By Region

6. North America Reproductive Genetics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Technology
  • 6.2.3. By Procedure Type
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Reproductive Genetics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Procedure Type
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Reproductive Genetics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Procedure Type
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Reproductive Genetics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Procedure Type
      • 6.3.3.2.4. By Application

7. Europe Reproductive Genetics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Technology
  • 7.2.3. By Procedure Type
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Reproductive Genetics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Procedure Type
      • 7.3.1.2.4. By Application
  • 7.3.2. Germany Reproductive Genetics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Procedure Type
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Reproductive Genetics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Procedure Type
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Reproductive Genetics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Procedure Type
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Reproductive Genetics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Procedure Type
      • 7.3.5.2.4. By Application

8. Asia-Pacific Reproductive Genetics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Technology
  • 8.2.3. By Procedure Type
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Reproductive Genetics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Procedure Type
      • 8.3.1.2.4. By Application
  • 8.3.2. India Reproductive Genetics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Procedure Type
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Reproductive Genetics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Procedure Type
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Reproductive Genetics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Procedure Type
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Reproductive Genetics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Procedure Type
      • 8.3.5.2.4. By Application

9. South America Reproductive Genetics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Technology
  • 9.2.3. By Procedure Type
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Reproductive Genetics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Procedure Type
      • 9.3.1.2.4. By Application
  • 9.3.2. Argentina Reproductive Genetics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Procedure Type
      • 9.3.2.2.4. By Application
  • 9.3.3. Colombia Reproductive Genetics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Procedure Type
      • 9.3.3.2.4. By Application

10. Middle East and Africa Reproductive Genetics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Technology
  • 10.2.3. By Procedure Type
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Reproductive Genetics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Procedure Type
      • 10.3.1.2.4. By Application
  • 10.3.2. Saudi Arabia Reproductive Genetics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Procedure Type
      • 10.3.2.2.4. By Application
  • 10.3.3. UAE Reproductive Genetics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Procedure Type
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Reproductive Genetics Market: SWOT Analysis

15. Competitive Landscape

• 15.1. CooperSurgical, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Centogene AG
• 15.3. Invitae Corporation
• 15.4. Illumina, Inc.
• 15.5. Myriad Genetics, Inc.
• 15.6. Thermo Fisher Scientific Inc.
• 15.7. Laboratory Corporation of America Holdings
• 15.8. Quest Diagnostics
• 15.9. Natera, Inc
• 15.10. Eurofins Scientific SE

16. Strategic Recommendations

17. About Us & Disclaimer